跳至主要内容
临床试验/NCT07097571
NCT07097571进行中(未招募)不适用

Comparison of the Efficacy of Proximal and Distal Suprascapular Nerve Blocks Under Ultrasound Guidance in the Treatment of Patients Diagnosed With Adhesive Capsulitis

Istanbul University - Cerrahpasa2 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2025年2月26日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
70
试验地点
2
主要终点
Pain Relief

研究概览

简要总结

This study aims to compare the efficacy of different suprascapular nerve block techniques in patients diagnosed with adhesive capsulitis.

Adhesive capsulitis, commonly known as frozen shoulder, is a condition characterized by pain and restricted range of motion in the shoulder joint, significantly affecting quality of life. The suprascapular nerve provides sensory innervation to the shoulder joint; therefore, nerve blockade is frequently used to alleviate pain. However, there are limited studies evaluating the difference in efficacy between proximal and distal suprascapular nerve blocks.

In this research, two different blockade techniques-at the suprascapular notch and the spinoglenoid notch-will be compared in patients diagnosed with adhesive capsulitis at Istanbul University-Cerrahpaşa between 2024 and 2026. The hypothesis of the study is that the block performed at the spinoglenoid notch provides pain relief comparable to the suprascapular notch block while resulting in less motor blockade.

Patients participating in the study will be randomly assigned to two groups. Both groups will receive an intra-articular corticosteroid injection into the shoulder joint, along with cold application, Codman exercises, and standard medical therapy. Pre- and post-treatment evaluations will include pain severity (NRS), shoulder function (Modified Constant Score), muscle strength, and range of motion.

The results will reveal which technique provides better improvement in shoulder external rotator and abductor muscle strength, shoulder function, and pain relief, thereby offering valuable insights to guide treatment approaches.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
35 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patients who have had shoulder pain, restricted range of motion (ROM), and night pain for at least 4 weeks

排除标准

  • •Age younger than 35 years or older than 75 years.
  • •Known allergy to the agents used for injection.
  • •History of trauma and/or surgery involving the same shoulder.
  • •Presence of uncontrolled diabetes mellitus and/or hypertension.
  • •Presence of severe chronic respiratory disease.
  • •Presence of severe heart failure.
  • •Administration of intra- or peri-articular steroid injection to the affected shoulder within the past 2 months.
  • •Radiographic evidence of calcific tendinitis, glenohumeral osteoarthritis, acromioclavicular joint osteoarthritis, or bone fracture.
  • •Full-thickness rotator cuff tear detected by shoulder ultrasonography.
  • •History of surgical intervention or recent/past fracture in the ipsilateral upper extremity.
  • •Presence of complex regional pain syndrome or vascular disease in the ipsilateral extremity.
  • •Known coagulation disorders.
  • •Cervical disc pathology causing radiculopathy.
  • •Presence of inflammatory or malignant diseases.
  • •History of cerebrovascular disease.
  • •Presence of mental impairment or severe psychiatric disorders.
  • •Pregnancy.

研究组 & 干预措施

Patients Receiving Suprascapular Nerve Block at the Suprascapular Notch

Active Comparator

干预措施: Glenohumeral Joint Injection and Suprascapular Nerve Block (Procedure)

Patients Receiving Suprascapular Nerve Block at the Spinoglenoid Notch

Active Comparator

干预措施: Glenohumeral Joint Injection and Suprascapular Nerve Block (Procedure)

结局指标

主要结局

Pain Relief

时间窗: Patients will be evaluated before the glenohumeral joint injection and suprascapular nerve block, as well as 1 hour, 1 week, and 1 month after the procedure.

Pain will be assessed using the Numerical Rating Scale (NRS), which ranges from 0 (no pain) to 10 (worst pain imaginable), at rest, during movement, at night, and overall, both before and after injections into the glenohumeral joint and suprascapular nerve block. Higher scores indicate worse pain outcomes.

Evaluation of the Strength of Shoulder External Rotation and Abduction.

时间窗: Patients will be assessed at baseline (pre-procedure), 1 week, and 1 month following the glenohumeral joint injection and suprascapular nerve block

Shoulder external rotation strength will be assessed in two different positions: with the arm at the side of the body and with the shoulder in 90 degrees of abduction. Additionally, shoulder abduction strength will be evaluated in two positions: with the shoulder in 90 degrees of abduction and in 90 degrees of abduction combined with 30 degrees of horizontal adduction.

Pain Relief

时间窗: Patients will be evaluated before the glenohumeral joint injection and suprascapular nerve block, as well as 1 hour, 1 week, and 1 month after the procedure.

Pain will be assessed using the Numerical Rating Scale (NRS), which ranges from 0 (no pain) to 10 (worst pain imaginable), at rest, during movement, at night, and overall, both before and after injections into the glenohumeral joint and suprascapular nerve block. Higher scores indicate worse pain outcomes.

Passive and Active Range of Motion of Shoulder

时间窗: Patients will be assessed at baseline (pre-procedure), and at 1 hour, 1 week, and 1 month following the glenohumeral joint injection and suprascapular nerve block.

The shoulder joint's active and passive range of motion will be measured with a goniometer

次要结局

  • The Numeric Rating Scale (NRS)(Assessments were performed before, 1 hour after, 1 week after, and 1 month after the glenohumeral joint injection and suprascapular nerve block.)
  • Modified Constant Murley Score(Assessments were performed before, 1 week after, and 1 month after the glenohumeral joint injection and suprascapular nerve block.)
  • The Numeric Rating Scale (NRS)(Assessments were performed before, 1 hour after, 1 week after, and 1 month after the glenohumeral joint injection and suprascapular nerve block.)
  • Modified Constant Murley Score(Assessments were performed before, 1 week after, and 1 month after the glenohumeral joint injection and suprascapular nerve block.)
  • Shoulder Disability Questionnaire(Assessments were performed before, 1 week after, and 1 month after the glenohumeral joint injection and suprascapular nerve block.)

研究者

发起方
Istanbul University - Cerrahpasa
申办方类型
Other
责任方
Principal Investigator
主要研究者

MUSA AVŞAR

medical doctor

Istanbul University - Cerrahpasa

研究点 (2)

Loading locations...

相似试验